Enfusion Alpha and Beta Analysis
| ENFNDelisted Stock | USD 10.76 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Enfusion. It also helps investors analyze the systematic and unsystematic risks associated with investing in Enfusion over a specified time horizon. Remember, high Enfusion's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Enfusion's market risk premium analysis include:
Beta 0.12 | Alpha (0.02) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Enfusion |
Enfusion Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Enfusion market risk premium is the additional return an investor will receive from holding Enfusion long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Enfusion. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Enfusion's performance over market.| α | -0.02 | β | 0.12 |
Enfusion Fundamentals Vs Peers
Comparing Enfusion's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Enfusion's direct or indirect competition across all of the common fundamentals between Enfusion and the related equities. This way, we can detect undervalued stocks with similar characteristics as Enfusion or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Enfusion's fundamental indicators could also be used in its relative valuation, which is a method of valuing Enfusion by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Enfusion to competition |
| Fundamentals | Enfusion | Peer Average |
| Return On Equity | 0.0442 | -0.31 |
| Return On Asset | 0.0305 | -0.14 |
| Profit Margin | 0.01 % | (1.27) % |
| Operating Margin | 0.03 % | (5.51) % |
| Current Valuation | 1.01 B | 16.62 B |
| Shares Outstanding | 94.8 M | 571.82 M |
| Shares Owned By Insiders | 4.73 % | 10.09 % |
Enfusion Opportunities
Enfusion Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 150000 shares by Oleg Movchan of Enfusion at 10.09 subject to Rule 16b-3 | 01/24/2025 |
2 | ENFN Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of Enfusion, Inc. Is Fair to Shareholders - The Bakersfield Californian | 02/24/2025 |
3 | Decoding Enfusion Inc A Strategic SWOT Insight | 03/04/2025 |
4 | Disposition of 11452 shares by Oleg Movchan of Enfusion at 11.393 subject to Rule 16b-3 | 03/06/2025 |
5 | MS cuts rating on Enfusion stock after Clearwaters acquisition bid - MSN | 03/20/2025 |
6 | Clearwater Analytics and Enfusion Announce Election Deadline for Enfusion Shareholders to Elect Form of Merger Consideration | 04/02/2025 |
7 | ENFN INVESTOR ALERT Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Enfusion, Inc. and Encourages Investors to Contact the Firm - ACCESS Ne... | 04/08/2025 |
About Enfusion Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Enfusion or other delisted stocks. Alpha measures the amount that position in Enfusion has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Enfusion Upcoming Company Events
As portrayed in its financial statements, the presentation of Enfusion's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Enfusion's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Enfusion's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Enfusion. Please utilize our Beneish M Score to check the likelihood of Enfusion's management manipulating its earnings.
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Enfusion
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Enfusion Stock
If you are still planning to invest in Enfusion check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enfusion's history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |